Answers are grounded in this paper and cite their sources.
Oxidative stress arising from imbalance between reactive oxygen species generation and antioxidant defense mechanisms contributes significantly to the pathogenesis of numerous chronic diseases including cancer, diabetes mellitus, cardiovascular disorders, and neurodegenerative conditions. While synthetic antioxidants such as butylated hydroxyanisole and butylated hydroxytoluene are conventionally employed to manage oxidative stress, their association with hepatotoxicity and carcinogenic potential necessitates exploration of safer alternatives. Medicinal plants have emerged as promising sources of natural antioxidants owing to their rich phytochemical composition and traditional therapeutic applications. This study investigated the in vitro antioxidant properties of hydroalcoholic stem extract of Acacia nilotica, a medicinal plant traditionally utilized in managing oxidative stress-related ailments. The plant material was collected, authenticated, dried, and extracted using analytical grade ethanol. Antioxidant activity was evaluated through 2, 2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay and hydroxyl radical scavenging assay at various concentrations ranging from 0.0625 to 1.0 mg/ml. The extract demonstrated concentration-dependent DPPH radical scavenging activity with IC₅₀ value of 0.22 mg/ml compared to ascorbic acid standard (IC₅₀ = 0.06 mg/ml). Hydroxyl radical scavenging activity exhibited an inverse concentration-dependent pattern with IC₅₀ value of 0.48 mg/ml versus 1.07 mg/ml for ascorbic acid. The strong antioxidant capacity correlates with the presence of phenolic compounds, flavonoids, and tannins detected through phytochemical screening. These findings validate the traditional use of Acacia nilotica in managing oxidative stress-related disorders and suggest its potential as a natural alternative to synthetic antioxidants. Further research on isolation and characterization of bioactive compounds alongside toxicity assessment is warranted to facilitate development of standardized therapeutic formulations.
No takes yet. Share an insight, caveat, or question.
Mekala et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: